1-4 of 4
L. Burt Nabors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials

Monika E. Hegi, Els Genbrugge, Thierry Gorlia, Roger Stupp, Mark R. Gilbert, Olivier L. Chinot, L. Burt Nabors, Greg Jones, Wim Van Criekinge, Josef Straub, Michael Weller
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (6): 1809–1816.
https://doi.org/10.1158/1078-0432.CCR-18-3181
Published: 15 March 2019
View article titled, <em>MGMT</em> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Open the PDF for <em>MGMT</em> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma

Jaishri O. Blakeley, Stuart A. Grossman, Andrew S. Chi, Tom Mikkelsen, Myrna R. Rosenfeld, Manmeet S. Ahluwalia, L. Burt Nabors, April Eichler, Ignacio Garcia Ribas, Serena Desideri, Xiaobu Ye
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 73–79.
https://doi.org/10.1158/1078-0432.CCR-18-0110
Published: 03 January 2019
View article titled, Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Open the PDF for Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Rationally Designed Pharmacogenomic Treatment Using Concurrent Capecitabine and Radiotherapy for Glioblastoma; Gene Expression Profiles Associated with Outcome

Jessica M. Grunda, John Fiveash, Cheryl A. Palmer, Alan Cantor, Hassan M. Fathallah-Shaykh, L. Burt Nabors, Martin R. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2890–2898.
https://doi.org/10.1158/1078-0432.CCR-09-3151
Published: 13 May 2010
View article titled, Rationally Designed Pharmacogenomic Treatment Using Concurrent Capecitabine and Radiotherapy for Glioblastoma; Gene Expression Profiles Associated with Outcome
Open the PDF for Rationally Designed Pharmacogenomic Treatment Using Concurrent Capecitabine and Radiotherapy for Glioblastoma; Gene Expression Profiles Associated with Outcome in another window
Includes: Supplementary data
Journal Articles

Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, L. Burt Nabors, Brian Chon, Tracy T. Batchelor
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (17): 5643–5646.
https://doi.org/10.1158/1078-0432.CCR-04-0159
Published: 08 September 2004
View article titled, Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate
Open the PDF for Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate in another window